跳至主要内容
临床试验/NL-OMON49389
NL-OMON49389已完成不适用

Functional magnetic resonance imaging of human hypothalamic responses to oral glucose ingestion in subjects with obesity before and after lifestyle intervention. - fMRI of hypothalamic function after lifestyle intervention.

eids Universitair Medisch Centrum0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Participants with a Body Mass Index (BMI) > 30 kg/m2 with obesity related
  • comorbidities. Allowed comorbidities are defined as follows:
  • - Insulin resistance (as defined by the HOMA index based on fasted
  • insulin/glucose)
  • - Dyslipidaemia
  • - Hypertension
  • - Arthrosis
  • - Sleep apnoea
  • - Fatty liver disease
  • - Polycystic Ovary Syndrome (PCOS)

排除标准

  • - Does not speak Dutch
  • - Cognitive impairment (IQ<80)
  • - Physical impairment that impairs movement therapy.
  • - Other underlying treatable causes of obesity
  • - Lack of motivation
  • - Behavioural problems that impair group therapy.
  • - Psychopathologies pathology that require other treatment
  • - Current desire to have children
  • - Diabetes mellitus type 2

研究者

相似试验